Stocks and Investing Stocks and Investing
Mon, May 3, 2021

Vamil Divan Maintained (ABBV) at Strong Buy with Increased Target to $128 on, May 3rd, 2021


Published on 2024-10-27 16:30:21 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $126 to $128 on, May 3rd, 2021.

Vamil has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Vamil


  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $144 on, Tuesday, March 30th, 2021
  • Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Friday, March 12th, 2021
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $135 on, Thursday, February 4th, 2021
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021

Contributing Sources